Cargando…

The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer

PURPOSE: Achieving complete cytoreduction (CCR) is crucial for a patient’s prognosis with advanced epithelial ovarian cancer (EOC). So far, prognostic predictors have failed to predict surgical outcome after neoadjuvant chemotherapy (NACT). In clinical trials, scores were used to predict operability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rawert, Friederike Luise, Luengas-Würzinger, Veronica, Claßen-Gräfin von Spee, Sabrina, Baransi, Saher, Schuler, Esther, Carrizo, Katharina, Dizdar, Anca, Mallmann, Peter, Lampe, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Gynecologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519707/ https://www.ncbi.nlm.nih.gov/pubmed/35357582 http://dx.doi.org/10.1007/s00404-022-06527-y

Ejemplares similares

Pelvic Exenteration for Recurrent Endometrial Cancer: A 15-Year Monocentric Retrospective Study
por: Fix, Nando, et al.
Publicado: (2023)

Opportunities and Limitations of Pelvic Exenteration Surgery
por: Lampe, Björn, et al.
Publicado: (2021)

Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
por: Chauhan, Sonali, et al.
Publicado: (2022)

Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients
por: Müller, Carolin, et al.
Publicado: (2020)

Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
por: Müller, Carolin, et al.
Publicado: (2021)

CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer
por: Lin, Yun, et al.
Publicado: (2021)

Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer
por: von Au, Alexandra, et al.
Publicado: (2022)

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

Is Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Effective in Ovarian Cancer With Peritoneal Metastasis?
por: Mohammad, Amad, et al.
Publicado: (2022)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer
por: Cornali, Tommaso, et al.
Publicado: (2017)

Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator: Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer
por: Siegenthaler, Franziska, et al.
Publicado: (2022)

Cytoreductive Surgery Under Aminolevulinic Acid-Mediated Photodynamic Diagnosis Plus Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Ovarian Cancer and Primary Peritoneal Carcinoma: Results of a Phase I Trial
por: Liu, Yang, et al.
Publicado: (2014)

Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference
por: Mei, Shirley, et al.
Publicado: (2023)

Primary Peritoneal Carcinosarcoma With Metastasis to the Umbilicus and Pancreas
por: Tanabe, Shohei, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility‐Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer
por: Zusterzeel, Petra L.M., et al.
Publicado: (2020)

Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2022)

Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS
por: Acs, Miklos, et al.
Publicado: (2023)

Executive Summary of the Ovarian Cancer Evidence Review Conference
por: Burke, William, et al.
Publicado: (2023)

Clinicopathological Parameters Associated With Peritoneal Involvement in Epithelial Ovarian Tumors
por: Hashmi, Atif A, et al.
Publicado: (2023)

Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
por: Najor, Anna, et al.
Publicado: (2023)

Impact of lymphadenectomy on short- and long-term complications in patients with endometrial cancer
por: Proppe, Louisa, et al.
Publicado: (2022)

Executive Summary of the Lower Anogenital Tract Cancer Evidence Review Conference
por: Chelmow, David, et al.
Publicado: (2023)

Cutaneous and Cerebral Metastases From Primary Peritoneal Clear Cell Carcinoma
por: Alves, Fátima R, et al.
Publicado: (2022)

A Rare Case of Primary Peritoneal Carcinoma With Large Bowel Metastasis
por: Jangam, Aishwarya, et al.
Publicado: (2023)

Encysted Peritoneal Tuberculosis Masquerading as Ovarian Tumour: A Case Report
por: Jiandani, Farah P, et al.
Publicado: (2023)

Mechanisms of peripheral sensitization in endometriosis patients with peritoneal lesions and acyclical pain
por: Velho, Renata Voltolini, et al.
Publicado: (2023)

Challenges and Considerations in Identifying the Origin of Peritoneal Carcinomatosis: A Case Report
por: Huang, Chih-kai, et al.
Publicado: (2023)

Embryologically based radical hysterectomy as peritoneal mesometrial resection (PMMR) with pelvic and para-aortic lymphadenectomy for loco-regional tumor control in endometrial cancer: first evidence for efficacy
por: Kimmig, Rainer, et al.
Publicado: (2015)

Trends in Uterine Cancer Mortality in the United States: A 50-Year Population-Based Analysis
por: Somasegar, Sahana, et al.
Publicado: (2023)

The application of risk models based on machine learning to predict endometriosis‐associated ovarian cancer in patients with endometriosis
por: Chao, Xiaopei, et al.
Publicado: (2022)

Correlation analysis of resected breast tissue and implant volume after mastectomy and its association with breast density
por: Malter, Wolfram, et al.
Publicado: (2021)

A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
por: Lavie, Ofer, et al.
Publicado: (2017)

Spiliotis-Farfarelos Maneuver for the Management of Small Bowel Obstruction and Frozen Pelvis in Patients With Peritoneal Metastasis
por: Spiliotis, John, et al.
Publicado: (2022)

Complete Pathologic Response Following Neoadjuvant Chemoradiotherapy and High-Dose-Rate Brachytherapy for Locally Advanced Endometrial Carcinoma
por: Horne, Zachary, et al.
Publicado: (2015)

Mammographic and Ultrasonographic Imaging Analysis for Neoadjuvant Chemotherapy Evaluation: Volume Reduction Indexes That Correlate With Pathological Complete Response
por: Mello, Juliana M, et al.
Publicado: (2022)

Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers
por: Blaj, Sebastian, et al.
Publicado: (2023)

Small Bowel Injury During Peritoneal Entry at Cesarean Section: A Five-Year Case Series
por: Ahmed, Husham A, et al.
Publicado: (2022)

ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer
por: Stålberg, Karin, et al.
Publicado: (2020)

A Case of Tubo-Ovarian Abscess in a 15-Year-Old Female After Appendectomy Complicated by Peritonitis
por: Campbell, Maryellen, et al.
Publicado: (2021)

Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study
por: Ouyang, Peilin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f6l98q6n8r0j1hs3rhjcmqscd9